Indication
Antithrombic Drug
1 clinical trial
2 products
Clinical trial
An Open Label, Balanced, Randomized, Two-treatment, Two-period, Two-sequence, Single Oral Dose, Cross Over Bioequivalence Study of Two Products of Apixaban 5mg Tablets in Normal, Healthy, Adult, Human Subjects Under Fasting ConditionStatus: Completed, Estimated PCD: 2023-03-06
Product
ApixabanProduct
Eliquis